Product image of Oramorph (Morphine Sulfate) supplied by GNH India

Oramorph

Active Ingredient:
Morphine Sulfate
Origin:
EU

Oramorph (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Oramorph, is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain, particularly when other analgesics are insufficient, and is used in adult and pediatric patients under strict medical supervision.

GNH India supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

L. Molteni And C. Dei F.Lli Alitti Società Di Esercizio S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Oramorph is an opioid analgesic that acts on the central nervous system to relieve pain in several clinical contexts.

  • Acute postoperative pain: Provides strong analgesia during the immediate recovery period after surgery.
  • Cancer‑related pain: Helps manage persistent pain associated with malignant disease.
  • Severe chronic non‑cancer pain: Used when pain is intense and other treatments have failed.

How It Works

  • Morphine sulfate binds primarily to μ‑opioid receptors in the central nervous system, inhibiting the release of excitatory neurotransmitters and reducing neuronal excitability. This receptor activation decreases the perception of pain and alters the emotional response to painful stimuli, producing analgesia.

Side Effects

Adverse reactions to morphine can vary in frequency and severity.

Common Side Effects

  • Constipation: Reduced gastrointestinal motility leading to hard stools.
  • Nausea and vomiting: Stimulation of the chemoreceptor trigger zone.
  • Drowsiness: Central nervous system depression.
  • Dry mouth: Decreased salivary secretion.
  • Pruritus: Histamine release causing itching.
  • Urinary retention: Decreased bladder contractility.

Serious or Rare Side Effects

  • Respiratory depression: Reduced drive to breathe, potentially life‑threatening.
  • Severe hypotension: Marked drop in blood pressure.
  • Opioid dependence or addiction: Development of physical or psychological reliance.
  • Anaphylaxis: Rare severe allergic reaction.
  • adrenal insufficiency: Suppression of the hypothalamic‑pituitary‑adrenal axis.
  • Myoclonus: Involuntary muscle jerks, especially at high doses.

Precautions & Warnings

When prescribing Oramorph, clinicians should evaluate patient‑specific factors and monitor for adverse events.

  • Assess renal and hepatic function: Adjust dosing in impairment.
  • Evaluate respiratory status: Avoid use in patients with severe respiratory compromise.
  • Review concomitant CNS depressants: Increased risk of sedation and respiratory depression.
  • Monitor for signs of dependence: Counsel patients on safe use.
  • Pregnancy and lactation: Use only if benefits outweigh risks.
  • Store at below 25°C: Keep in the original container, protect from moisture and light.

Avoid Interactions

Morphine interacts with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Benzodiazepines: Combined CNS depression can cause profound respiratory depression.
  • Barbiturates: Potentiates sedative effects and increases overdose risk.
  • MAO inhibitors: May precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • Anticholinergics: May worsen constipation.
  • Loop diuretics: Can enhance hypotensive effects.
  • Selective serotonin reuptake inhibitors (SSRIs): May increase risk of serotonin syndrome.
  • Antihistamines: May add to sedative load.
  • Alcohol: Potentiates CNS depression.

Frequently Asked Questions

Oramorph contains morphine sulfate, an opioid analgesic used to treat moderate to severe pain. It is commonly prescribed for postoperative pain, cancer‑related pain, and severe chronic non‑cancer pain when other analgesics are insufficient.

Morphine sulfate binds to μ‑opioid receptors in the brain and spinal cord, inhibiting the release of neurotransmitters that transmit pain signals. This receptor activation reduces the perception of pain and modifies the emotional response to painful stimuli.

The appropriate dose of Oramorph is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, age, weight, and organ function. Dosage regimens are individualized and should follow local prescribing guidelines.

Morphine crosses the placenta and is excreted in breast milk. Use during pregnancy or lactation is only recommended when the potential benefit justifies the potential risk to the fetus or infant. Clinicians should assess each case carefully.

To request Oramorph, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oramorph (morphine sulfate) is a benchmark opioid with well‑characterised efficacy and safety. Compared with weaker opioids such as codeine, morphine provides stronger analgesia but carries a higher risk of respiratory depression and dependence, requiring careful monitoring.

Store Oramorph at temperatures below 25 °C, in its original packaging, protected from moisture and light. Keep the product out of reach of children and dispose of any unused medication according to local regulations.

Oramorph is typically formulated for oral administration, taken as directed by a healthcare professional. The medication may be available as tablets, capsules or oral solution, and should be swallowed whole unless otherwise instructed.

The most serious risks include respiratory depression, severe hypotension, opioid dependence or addiction, and rare allergic reactions such as anaphylaxis. Patients should be monitored closely for signs of these events, especially during dose initiation and escalation.

Oramorph is contraindicated in patients with known hypersensitivity to morphine or other opioids, those with severe respiratory insufficiency, acute or severe bronchial asthma, and individuals who have taken monoamine oxidase inhibitors within the past 14 days.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Morphine Sulfate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT